SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
AMARIN
(NQNM:AMRN Last Sale: 7.62 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (AMRN : $7.62)
$2,752,356 million Market Cap at Market Close, July 1, 2022
Employs 18.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
The Oval Shelbourne Road Ballsbridge Research Report Earnings Snapshot - Last 11/06/18
First Floor Block 3 Fact Sheet
Dublin, Financial Statements
Ireland Peer Comparison
Phone: 353 1 669 9020 Annual Reports

Joseph S. Zakrzewski, Chmn./CEO, John F. Thero, CFO
Pharmaceutical company developing products across a range of therapeutic areas using its proprietary oral and transdermal drug delivery technologies. Formerly ETHICAL HOLDINGS LTD, until Jan. 10, 2000. April 18, 2011, indicated medicinal-grade fish oil drug AMR101 significantly lowered triglyceride levels without raising "bad" LDL cholesterol, according to results of a late-stage study.
Historical Charts    Technical Analysis
No Historical Data available for AMRN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common AMRN $7.62 $7.62 0 .0 $6.96 $7.64 7,616,855 $6.96 $7.64 361,201,553
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
12-JAN-00 ETHCY Symbol Changed to AMRN
13-NOV-98 ETHYD Symbol Changed to ETHCY
16-OCT-98 ETHYD Split 1 for 8
16-OCT-98 ETHCY Symbol Changed to ETHYD

A43
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex